SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-13-016202
Filing Date
2013-03-13
Accepted
2013-03-13 15:25:17
Documents
1
Period of Report
2013-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2124
  Complete submission text file 0001209191-13-016202.txt   4067
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Reporting) CIK: 0000944809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54910 | Film No.: 13687363
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations